Literature DB >> 8448020

T cell priming in situ by intratracheally instilled antigen-pulsed dendritic cells.

C E Havenith1, A J Breedijk, M G Betjes, W Calame, R H Beelen, E C Hoefsmit.   

Abstract

In the present study, splenic dendritic cells (DC) and alveolar macrophages (AM) were pulsed with antigen in vitro and subsequently intratracheally instilled to test whether these cells have the capacity to sensitize T cells in the draining lymph nodes of the lung. The data demonstrate that antigen-pulsed DC, instilled in the bronchoalveolar lumen, induce antigen-specific T cell priming in vivo in the draining lymph nodes. T cell priming is only seen with viable but not with killed antigen-pulsed DC. Amounts as low as 5 x 10(3) to 10 x 10(3) cells can still induce some responsiveness. In addition, it was found that instillation of viable as well as killed pulsed Ia-negative AM also leads to T cell priming, although about 10 times higher numbers of cells had to be used in comparison with DC. The results suggest that DC instilled in the bronchoalveolar lumen present antigen directly to naive T cells, whereas for AM other mechanisms are involved.

Mesh:

Substances:

Year:  1993        PMID: 8448020     DOI: 10.1165/ajrcmb/8.3.319

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  11 in total

1.  Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus.

Authors:  Gabrielle T Belz; Christopher M Smith; Lauren Kleinert; Patrick Reading; Andrew Brooks; Ken Shortman; Francis R Carbone; William R Heath
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-26       Impact factor: 11.205

2.  Interstitial lung macrophages interact with dendritic cells to present antigenic peptides derived from particulate antigens to T cells.

Authors:  J L Gong; K M McCarthy; R A Rogers; E E Schneeberger
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

3.  Enrichment and characterization of dendritic cells from human bronchoalveolar lavages.

Authors:  C E Havenith; J M van Haarst; A J Breedijk; M G Betjes; H C Hoogsteden; R H Beelen; E C Hoefsmit
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

4.  Induction of IL-10 producing CD4+ T cells with regulatory activities by stimulation with IL-10 gene-modified bone marrow derived dendritic cells.

Authors:  C-L Fu; Y-H Chuang; H-Y Huang; B-L Chiang
Journal:  Clin Exp Immunol       Date:  2008-06-28       Impact factor: 4.330

5.  Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature.

Authors:  U O'Doherty; M Peng; S Gezelter; W J Swiggard; M Betjes; N Bhardwaj; R M Steinman
Journal:  Immunology       Date:  1994-07       Impact factor: 7.397

6.  Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses.

Authors:  A Bender; L K Bui; M A Feldman; M Larsson; N Bhardwaj
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

7.  The antigen-presenting activities of Ia+ dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen.

Authors:  W Xia; C E Pinto; R L Kradin
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

8.  Differential T cell function and fate in lymph node and nonlymphoid tissues.

Authors:  Nicola L Harris; Victoria Watt; Franca Ronchese; Graham Le Gros
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

9.  Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo.

Authors:  K Inaba; M Inaba; M Naito; R M Steinman
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

10.  Proliferating dendritic cell progenitors in human blood.

Authors:  N Romani; S Gruner; D Brang; E Kämpgen; A Lenz; B Trockenbacher; G Konwalinka; P O Fritsch; R M Steinman; G Schuler
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.